Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
Mirna Chehade(Icahn School of Medicine at Mount Sinai), Arsalan Shabbir(Regeneron (United States)), Elizabeth Laws(Sanofi (United States)), Jennifer Maloney(Regeneron (United States)), Jennifer D. Hamilton(Regeneron (United States)), Jonathan M. Spergel(University of Pennsylvania), Renata Martincova(Icahn School of Medicine at Mount Sinai), Eric Mortensen(Regeneron (United States)), Matthew P. Kosloski(AbbVie (United States)), Lila Glotfelty(Icahn School of Medicine at Mount Sinai), Eilish McCann(Regeneron (United States)), Carin Samuely(Icahn School of Medicine at Mount Sinai), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Ruiqi Liu(Huazhong University of Science and Technology), Robert D. Pesek(Arkansas Children's Hospital), Evan S. Dellon(University of North Carolina at Chapel Hill), Margaret Collins(Cincinnati Children's Hospital Medical Center), Ikuo Hirano(Northwestern University)
Cited by 7
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
|Gastroenterology|2015|996